summary
Introduced
01/29/2025
01/29/2025
In Committee
04/01/2025
04/01/2025
Crossed Over
03/17/2025
03/17/2025
Passed
04/04/2025
04/04/2025
Dead
Signed/Enacted/Adopted
04/10/2025
04/10/2025
Introduced Session
95th General Assembly (2025 Regular)
Bill Summary
AN ACT TO AMEND THE PRIOR AUTHORIZATION TRANSPARENCY ACT; AND FOR OTHER PURPOSES.
AI Summary
This bill amends the Prior Authorization Transparency Act to expand and clarify the "gold card program," which allows healthcare providers to become exempt from prior authorization requirements. The bill introduces a new definition for the gold card program and modifies several key provisions related to how healthcare insurers evaluate and grant exemptions to providers. Specifically, the bill changes the timeline and criteria for evaluating a healthcare provider's prior authorization requests, extends the time providers have to submit medical records, and provides more detailed requirements for how insurers must notify providers about their exemption status. The bill also updates provisions related to prescription drugs and pharmaceutical services, establishing a process for determining which medications may be exempt from the gold card program. Additionally, the bill creates a more robust appeals process for disallowing prior authorizations, including provisions for independent review and potential cost reimbursement. These changes aim to streamline the prior authorization process, reduce administrative burdens on healthcare providers, and create more transparency in how insurers review and approve medical services and prescriptions.
Committee Categories
Business and Industry
Sponsors (2)
Last Action
Notification that HB1301 is now Act 511 (on 04/10/2025)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...